For the first nine months of this year, revenues from sales decreased by 3% compared to the same period of 2015, including 1% increase of domestic sales and a 5% decrease of export sales. “We are witnessing a positive trend in September, but it is hard to forecast whether it will be stable. However, we managed to a certain extent to compensate the weaker performance of the Russian market in the first half of this year.”, comments Ognian Donev, PhD, Chariman of the Board of Directors and Executive director of Sopharma AD.
Revenues from sales
6 October 2016